Introduction: Acinetobacter baumannii is one of major causative agents of severe, life-threatening hospital infections (HIs), especially in intensive care units (ICUs). Our aim was to discover the risk factors associated with the emergence of HIs caused by carbapenem-resistant Acinetobacter baumannii (CRAB), as well as those associated with death in patients who suffer from such infections. Methodology: A prospective cohort study was conducted over a five-year period in the medical-surgical ICU of the Clinical Centre in Kragujevac, Serbia. The study group comprised patients who had HIs caused by CRAB, while the control group comprised patients infected with carbapenem-sensitive Acinetobacter baumannii. Results: In total, 137 patients developed HIs caused by Acinetobacter baumannii. The mean age of the patients was 59.65 ± 16.08 years, and 99 (72.26%) of them were males. In 95 patients (69.35%), the infection was caused by CRAB. There were six independent risk factors for CRAB infections: use of mechanical ventilation, previous stay in another department, stay in ICU for more than a month, and previous use of carbapenems, aminoglycosides, and metronidazole. Three independent risk factors were found for death in patients with HIs caused by CRAB: use of mechanical ventilation, previous stay in another department, and previous use of carbapenems. Conclusions: The results of this study can be helpful when identifying patients with risk of HIs caused by CRAB and in planning preventive measures. Modification of known risk factors and appropriate institutional policy of antibiotic utilization are important measures that may decrease the incidence and mortality of such infections.
Introduction
Modern medicine is facing growing problems related to hospital infections (HIs) caused by microorganisms resistant to available antibiotics. An important example of such a microorganism is Acinetobacter baumannii (A. baumannii), which rapidly develops resistance to multiple antimicrobial drugs [1] . A. baumannii became a major causative agent of severe, life-threatening HIs such as pneumonia, wound infections, meningitis, urinary tract infections, central venous catheter-related infections, and bacteremia, especially in intensive care units (ICUs) [2] [3] [4] [5] .
Carbapenems are the antibiotics of choice for treatment of serious infections caused by A. baumannii. However, there are several studies that report a constant increase of carbapenem-resistant strains of A. baumannii (CRAB) causing HIs. An additional problem is the multidrug-resistant nature of such isolates, which further complicates treatment of HIs due to the limited choice of effective antibiotics.
Only a handful of studies have dealt with risk factors associated with HIs caused by CRAB. Previous studies have focused mainly on outbreaks of A. baumannii and did not discriminate between colonized and infected patients [6, 7] . Additional knowledge is required about prevention of HIs caused by A. baumannii and the optimal choice of therapy.
The aim of our study was to discover the risk factors associated with the emergence of HIs caused by CRAB, as well as those associated with death in patients who suffer from such HIs.
Methodology
A prospective cohort study was conducted during the period 1 January 2011 to 31 December 2015 in the medical-surgical ICU of the Clinical Centre in Kragujevac, Serbia, which has 18 hospital beds and is attended annually by about 850 critically ill patients. During this period, all adult patients (over 18 years of age) admitted to the ICU who developed HIs caused by A. baumannii of any localization were included in the study. The criterion for exclusion was the isolation of pathogens within 48 hours after admission to an ICU. In addition, if microbiological tests were repeated on the samples from the same location, only the first isolate was analyzed.
The study group comprised patients who had HIs caused by CRAB, while the control group comprised patients infected with A. baumannii sensitive to carbapenems (CSAB).
Diagnosis of HIs caused by A. baumannii and their anatomical localization in each patient were assessed according to the criteria of the Centers for Disease Control (CDC) [8] . Surveillance of HIs included daily clinical examination of the patients and daily review of the patient's medical record and all microbiological and laboratory data. In order to exclude patients colonized with A. baumannii, each of the cases was analyzed by the study group, and more complex cases were evaluated by a special study group composed of three independent experts in infectious diseases. Each patient was followed to the final outcome (cure and discharge from hospital or death).
Data on potential risk factors were recorded on individual forms for each patient and included the following: (i.) intrinsic factors: gender, age, the existence of co-morbidities or conditions (diabetes mellitus, cancers of different localization, injury, hypertension); and (ii.) factors related to healthcare: previous hospitalization in another ward of the same hospital, urgent admission, dates of admission and discharge (both at hospital and ICU), diagnostic and therapeutic procedures performed on a patient (venous catheters, urinary catheter, mechanical ventialtion, surgery), date of the first isolation of positive A. baumannii culture, and data about administered antibiotics. Prior exposure to antibiotics was defined as administration of a systemic antimicrobial agent for at least 24 hours during the 14-day period before isolation of A. baumannii.
Isolation and identification of agents causing HIs was done using conventional biochemical methods in the microbiology laboratory of the Clinical Centre in Kragujevac [9] . Interpretation of the results was done according to the guidelines issued by the Clinical and Laboratory Standards Institute [10] . Sensitivity of the isolates was tested to the following antibiotics: amoxicillin+clavulanic acid (30 μg/mL), piperacillintazobactam (110 μg/mL), cefotaxime (30 μg/mL), ceftriaxone (30 μg/mL), ceftazidime (30 μg/mL), cefepime (30 μg/mL), imipenem (10 μg/mL), meropenem (10 μg/mL), gentamicin (10 μg/mL), amikacin (30 μg/mL), ciprofloxacin (5 μg/mL), trimethoprim-sulfamethoxazole (2.5 μg/mL), and tigecycline (15 μg/mL). CRAB was determined if the A. baumannii isolate was resistant to both imipenem and meropenem. In cases of discrepancy, imipenem resistance served as the reference. Multi-resistance was defined as acquired non-susceptibility to at least one agent from three or more different antibiotic groups, and pan-resistance as non-susceptibility to all antimicrobial categories [11] .
An additional nested comparative study was done on patients who died from HIs. Mortality was defined as death documented to have occurred within 30 days following infection with A. baumannii. The patients who died after CRAB infection were compared to the patients who died after CSAB infection.
The study was approved by the ethics committee of the Clinical Centre, Kragujevac.
The data were analyzed by descriptive statistics, using measures of central tendency (mean), variability (standard deviation from the mean), and relative numbers. After testing for normality of the data distribution using the Kolmogorov-Smirnov test, significance of difference in values of continuous variables between the study groups was tested by student's t-test for independent samples. Significance of difference in categorical variables between the study groups was tested by the Chi-square test or Fisher's test (when values in some cells of contingency tables were lower than five, or zero). The differences were considered significant if probability of a null hypothesis was below 0.05. Associations between putative risk factors and the study outcomes were tested by univariate and multivariate logistic regressions, and expressed as crude or adjusted odds ratios. All calculations were done in SPSS for Windows software, version 18 (Chicago: SPSS Inc.).
Results
During the observed period, 137 patients admitted to the ICU developed HIs caused by A. baumannii, based on the pre-defined criteria. Themean age of the patients was 59.65 ± 16.08 years (range: 19-91 years), and 99 (72.26 %) of them were males. In 95 patients (69.35%), the infection was caused by CRAB. The difference between study groups in relation to the sites of HIs was not statistically significant (p > 0.05). The most common types of infections in the group with CRAB and in the group with CSAB were pneumonia (56.8% versus 61.9%, respectively) and surgical site infection (17.9% versus 19.0%, respectively), followed by bloodstream infection (20.0% versus 11.9%, respectively), urinary tract infection (2.1% versus 4.8%, respectively), and other infections (3.2% versus 2.4%, respectively).
Results of the univariate analyses of putative risk factors for acquiring HIs caused by CRAB, including clinical characteristics, invasive procedures, and prior therapy, are shown in Table 1 . The following risk factors were significantly associated with CRAB infections: comorbidity such as hypertension or cancer, concomitant HI, placement of central venous catheter or urinary catheter, use of mechanical ventilation, previous stay in another department, prolonged stay in hospital and ICU, hospitalization longer than one month, prolonged stay in hospital until infection, number of prescribed antibiotics and their prolonged Results of the univariate analyses of the risk factors for death in patients with HIs caused by CRAB are shown in Table 2 . The following risk factors were significantly associated with death in patients with Table  2 ). The Hosmer-Lemeshow goodness-of-fit test for this logistic regression model was χ 2 = 1.561 ;p = 0.992. The tested A. baumannii isolates showed high rates of resistance (70%-100%) to the majority of antibiotics except tigecycline (Table 3) . However, a statistically significant difference in resistance rate between CRAB and CSAB isolates was only observed concerning cefepime (74.4% versus 90.2%, respectively; p = 0.042). During the study period, outbreaks of hospital infections caused by A. baumanniiwere not registered.
Discussion
During the last decade, A. baumannii came into the focus of healthcare systems because the incidence of HIs caused by this bacterium is constantly rising; it successfully survives in hospital environments and acquires resistance to a wide spectrum of antibiotics [12] .
The fact that mechanical ventilation was the only invasive medical procedure associated with HIs caused by CRAB in our study is not surprising, because other researchers reported the same findings [13, 14] . This procedure is frequently used in patients with respiratory failure, poor gas exchange, or increased difficulty breathing. It is related to lung injury and adverse neurological outcomes, and it also opens the door for infectious agents. Microorganisms from the environment adhere to ventilator tubes and make a biofilm, which is out of reach of antibiotics and neutrophils. Additionally, these usually critically ill patients demand frequent and intensive contact with medical staff during care (introduction of venous catheters, endotracheal intubation, placement of urinary catheter, administration of drugs, etc.), which may disrupt protective barriers. This is why some authors have suggested that significant reduction in the frequency of HIs can be achieved by using noninvasive ventilation instead, such as nasal continuous positive pressure ventilation or nasal synchronized intermittent mandatory ventilation.
Previous stays in another department (in the same or in another hospital) increased the risk of CRAB infection 8.2 times (95% CI = 1.1-62.6; p = 0.042), and also increased the risk of death, which can be explained by increased exposure to microorganisms in the hospital environment, extension of hospitalization, or the use of antibiotics that leads to development of resistance [13, 14] . Rosa et al. [15] reported that patients exposed to a contaminated hospital environment were at 2.77 times greater risk of acquiring CRAB than were unexposed patients (95% CI = 1.5-5.1; p = 0.002).
Our study showed an association between HIs caused by CRAB and stays in the ICU for longer than a month (OR = 22.2; 95% CI = 1.2-420.4; p = 0.039), which was expected because previous studies reported the same finding. Baran et al. [16] showed that risk of this infection was three times higher for patients in an ICU (95% CI = 1.4-6.9; p = 0.005). Playford et al. [17] , in a retrospective case/control study, found that prolonged ICU stay (median length of stay: 15 days; 95% CI = 9-21 days) and prolonged hospital stay (30 Colonization of patients with such bacterial clones usually precedes infection, which is a consequence of drop in mechanisms of defense against microorganisms or utilization of invasive medical procedures. An additional factor that promotes colonization and infection by drug-resistant pathogens in ICU patients is exposure to antimicrobial therapy. In many ICUs, broad-spectrum antibiotics are predominantly used, which select multi-resistant bacterial strains. Prolonged stay in ICU increases the chances of contact with patients who are already colonized or infected with multi-resistant pathogens. The patients in ICUs are frequently elderly and have comorbidities, which further weakens their immunity and defense against infection. Furthermore, in countries with limited resources such as Serbia, ICUs are usually understaffed and overpopulated with patients, a situation that creates opportunity for neglect of aseptic techniques and basic hygiene, leading to emergence of HIs and further spread of resistant microbes from patient to patient [18] .
Earlier studies also showed that previous exposure to antibiotics is maybe the most important risk factor for HIs caused by multi-resistant pathogens. In our study, previous exposure to antibiotics was defined as at least 24 hours of therapy with antibiotics within 14 days prior to isolation of A. baumannii. Many of our patents received several antibiotics before the microbiological analysis became positive. Previous exposure to carbapenems predisposed patients in our study to HIs caused by CRAB (OR = 54.8; 95% CI = 2.6-1147.4; p = 0.01); Sheng et al. [19] reported similar findings, though the strength of association was lower (OR = 2.6; 95% CI = 1.4-5.4; p = 0.02). These results underline the necessity for strict control of carbapenem prescription in order to preserve their efficacy in the future, since these antibiotics are still a mainstay in the treatment of serious infections due to A. baumannii. Hospitals that introduced control of carbapenem prescriptions succeeded in halting further increase of A. baumannii resistance to this group of antibiotics.
Aminoglycosides, especially amikacin, are widely used in empiric therapy of critically ill patients, so their association with HIs caused by CRAB has broad relevance. Risk of HIs caused by CRAB after previous use of aminoglycosides was 11.8 times higher (95% CI = 1.4-98.5; p = 0.022) in our study, which is in accordance with the results of some recent studies [20] . This should be taken into account when evaluating potential benefits and harms of administering an aminoglycoside to a patient in the ICU.
Metronidazole is also frequently used in critically ill patients in the ICU. Our study confirmed the results of other authors that linked previous use of metronidazole with the emergence of HIs caused by CRAB [21] . However, how metronidazole predisposes patients for HIs caused by CRAB is not clear; we could only speculate that decreased burden of anaerobic bacteria creates empty space ready to be invaded by multi-resistant hospital flora, including A. baumannii.
In our study, previous use of piperacillintazobactam, secondand third-generation cephalosporins, ciprofloxacin, or vancomycin were not associated with HIs caused by CRAB after adjustment for other variables, although ciprofloxacin and vancomycin showed significant influence when taken separately (p = 0.040 and p < 0.001, respectively). An explanation could be found in the lower utilization rate of these antibiotics in patients from our study. Broadspectrum antibiotics, like the ones mentioned, help to select multi-resistant bacterial strains because they eradicate concurrent (yet sensitive) microorganisms.
A particularly worrying result of our study was the high resistance rate of CRAB isolates (> 75%) to other antibiotics. It is important to have this in mind when choosing the most appropriate antibiotic for empirical therapy. To date, A. baumannii has become resistant to almost all available antimicrobial agents [22] .
A large multicenter study that included 266 medical centers showed regional variability of A. baumannii sensitivity to imipenem; it was marked from good in North America and Europe (≥ 74%) to poor or moderate in Latin America and Asia/Pacific Rim (60.6% and 69.2%, respectively) [23] . However, an increase in the incidence of A. baumannii-resistant strains was reported worldwide; America-wide surveillance data demonstrated that resistance to carbapenems increased nearly eightfold, from 5.2% in 1999 to 40.8% in 2010 [24] . European surveillance data from 2012 [25] showed that the A. baumanniifrom ICUs is resistant in 68.8% of cases, which is a similar rate to that found in our study. Multi-and pan-resistant strains makes treating patients very difficult because they cause prolonged hospitalization, increased treatment costs, and increased hospital mortality [26] . One of the most important elements of therapeutic approach nowadays is good knowledge of local A. baumannii resistance patterns [27] .
Our study had certain limitations. First, it was a single-center study, which may introduce institutional bias concerning choice of participants or medical practice. Second, we were not able to conduct laboratory testing of mechanisms of A. baumannii resistance to antibiotics.
Conclusions
This study showed that mechanical ventilation, previous stay in another department, stay in an ICU for more than a month, and previous use of certain antibiotics (carbapenems, aminoglycosides, and metronidazole) are independent risk factors for the development of CRAB. Furthermore, risk factors for death in patients with HIs caused by CRAB are use of mechanical ventilation, previous stay in another department and previous use of carbapenems.
